Not Signed In - Enrollment In Amoxicillin PULSYS Phase III Trial Completed
Fri, 02 Jun 2006 06:00 AM EST
... AdvancisPharmaceutical Corporation (Nasdaq: AVNC), a pharmaceutical company focused on developing and commercializing novel anti-infective products, todayannounced that it has completed enrollment in the Company's AmoxicillinPULSYS Phase III clinical trial for the treatment ofpharyngitis/tonsillitis due to Group A streptococcal infections. [click link for full article] ...
Related Topics
- Clinical Trials
- Amoxicillin
- Antithrombin III
- Familial Dysautonomia
- Lansoprazole, Clarithromycin and Amoxicillin
- Amoxicillin and Clavulanate Potassium
- Food Recommendations: South Beach Diet - Phase 2
- Food Recommendations: South Beach Diet - Phase 1
- Congenital antithrombin III deficiency
- Cranial mononeuropathy III - diabetic type
- Cranial mononeuropathy III - compression type
- Antithrombin
- Osteogenesis imperfecta, type III
- Desipramine
- Trastuzumab
- Amoxicillin Oral Suspension
- Eletriptan
- Tarceva
- Amoxicillin and Clavulanate Potassium Oral Suspension
- Cardiovascular Health
email this page
print this page
bookmark this page
feedback on this page
